Progyny Inc (PGNY)

Cash ratio

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020
Cash and cash equivalents US$ in thousands 162,314 91,480 94,960 114,959 97,296 158,075 170,570 155,320 120,078 72,520 54,730 38,821 91,413 92,224 48,747 29,820 70,305 53,965 49,392
Short-term investments US$ in thousands 65,640 144,240 167,228 256,872 273,791 177,477 111,925 52,569 69,222 68,473 67,655 66,855 28,005 22,086 45,221 77,095 38,994 50,995 41,984
Total current liabilities US$ in thousands 168,627 208,471 225,375 205,919 185,950 193,419 193,900 206,867 159,536 156,868 144,897 128,717 98,824 104,484 98,785 100,998 77,786 74,166 57,668
Cash ratio 1.35 1.13 1.16 1.81 2.00 1.73 1.46 1.00 1.19 0.90 0.84 0.82 1.21 1.09 0.95 1.06 1.41 1.42 1.58

December 31, 2024 calculation

Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($162,314K + $65,640K) ÷ $168,627K
= 1.35

The cash ratio of Progyny Inc has shown some fluctuations over the past few years. The cash ratio measures the company's ability to cover its current liabilities with its cash and cash equivalents. A higher cash ratio indicates a stronger ability to cover short-term obligations.

From June 30, 2020, to December 31, 2021, the cash ratio remained relatively stable, ranging from 1.58 to 1.21. This suggests that Progyny had a comfortable level of liquidity to meet its short-term liabilities during this period.

However, from March 31, 2022, to June 30, 2024, the cash ratio experienced a downward trend, declining to as low as 0.82. This may indicate a potential strain on the company's ability to cover its short-term obligations with cash on hand during this period.

On a positive note, from September 30, 2024, to December 31, 2024, the cash ratio showed a slight improvement, reaching 1.35. This uptick suggests a better liquidity position for Progyny at the end of 2024.

Overall, while there have been fluctuations in the cash ratio of Progyny Inc, it is important for investors and stakeholders to monitor this ratio to assess the company's short-term liquidity position and ability to meet its immediate financial obligations.


Peer comparison

Dec 31, 2024

Company name
Symbol
Cash ratio
Progyny Inc
PGNY
1.35
DaVita HealthCare Partners Inc
DVA
0.31
Sotera Health Co
SHC
1.29